Le Lézard
Classified in: Environment, Health
Subject: CSR

VSP Vision Releases 2023 Social Responsibility Impact Report; Announces More Than 4 Million People Helped Through VSP Vision Eyes of Hope


2023 Impact Report spotlights the company's advancements in accelerating health equity, advancing sustainability, and empowering diversity, equity, and inclusion 

RANCHO CORDOVA, Calif., April 17, 2024 /PRNewswire/ -- Today, VSP Visiontm released its 2023 Impact Report, which highlights the company's progress toward its corporate social responsibility (CSR) commitments. The second annual report provides details on how VSP Vision continues to collaborate with its network of optometrists, community partners and employees to accelerate health equity, empower diversity, equity, and inclusion, and advance sustainability.

VSP Vision releases 2023 Impact Report, highlighting progress toward its corporate social responsibility commitments.

 In 2023 alone, VSP Vision invested nearly $13.5 million in direct and in-kind funding to positively impact communities and increase equitable access to vision care. It also increased the number of frames made from sustainable, recycled and biobased materials to 33%, launched a new scholarship to help advance the next generation of optometrists, and removed the equivalent of 39 tons of carbon dioxide from the air by using more sustainable shipping boxes.

"We are proud to report the progress we're making through meaningful collaboration with our stakeholders and partners to help build a future that is more equitable, inclusive and sustainable," said VSP Vision President and CEO Michael Guyette. "As we celebrate these milestones and achievements, we are mindful that advancing our social responsibility efforts is a journey and we will continue to hold ourselves accountable to making progress so that, together, we contribute to a world where everyone can bring their best vision to life."

Additional Highlights from the 2023 Impact Report

Accelerating Health Equity:

Empowering Diversity, Equity and Inclusion:

Advancing Sustainability: 

"I feel proud to work for a company that is committed to providing equitable access to eye care, fostering employee growth and a strong culture of belonging, and making a positive impact on the planet and communities we serve," said Christina Watkins, VSP Vision Supervisor of Client Management Operations, who is also a Business Resource Group member and Employee Giving ambassador.

Through VSP Hearts at Work, the company's employee giving and volunteering platform, employees supported more than 700 causes by logging 9,000 volunteer hours and raising $441,000. The company also launched its inaugural VSP Vision Volunteer Month in April 2023, where 114 employee volunteers logged more than 700 hours with charitable causes in one month alone.

Learn more about the company's commitment to social responsibility.

About VSP Vision
At VSP Visiontm, our purpose is to empower human potential through sight. As the first national not-for-profit vision benefits company, this is what drives everything we do. For nearly 70 years, VSP has been the leader in health-focused vision care. Every day, the people that power our complementary businesses?VSP® Vision Care, Marchon Eyewear, Inc., Visionworks®, Eyefinity®, Eyeconic, VSP® Optics, and VSP® Ventures?work together to create a world where everyone can bring their best vision to life. That means providing affordable access to eye care and eyewear for more than 85 million members through a network of more than 41,000 doctors. It also means expanding access to vision care to those disadvantaged by income, distance, or disaster through VSP Visiontm Eyes of Hope®. To date, more than 4 million people in need have received access to no-cost eye care and eyewear through one of our Eyes of Hope programs. Learn more about how we're reinvesting in greater vision, health, and opportunities for all at vspvision.com.

Media Contact
Candace Koehler
[email protected] 

SOURCE VSP Vision


These press releases may also interest you

at 05:05
Sphere Fluidics, a leading provider of innovative microfluidics-based solutions for single-cell analysis and isolation, today announced the appointment of Dale Levitzke as CEO with immediate effect, as Dr. Frank F. Craig, current CEO and co-founder,...

at 05:05
Scenic Biotech, a pioneer in the field of modifier therapies for severe genetic disorders, today announced that it has entered into a research collaboration with Bristol Myers Squibb to accelerate the development of Bristol Myers Squibb's drug...

at 05:00
As PetSafe® continues to lead the way in pet-tech innovations, we are proud to introduce the next evolution in pet fountains: the PetSafe® Outlasttm 90 oz Pumpless Pet Fountain with patented HydroSpintm technology....

at 05:00
BioMed X, a German biomedical research institute, announces the start of a new research project in partnership with Merck at its site in Heidelberg, Germany. The main objective of the project is to develop novel immunotherapeutic strategies to...

at 04:52
Foresee Pharmaceuticals (TPEx: 6576), ("Foresee") today announced that the first subject has been dosed in its Phase 1 clinical trial of FP-020 in Australia. The Phase 1 clinical trial is a randomized, double-blind, placebo-controlled,...

at 04:09
A news report from China Daily: The 2024 ZGC Forum in Beijing showcased a wide range of latest technological innovations. The event ran from April 25 to 29 and comprised 128 activities, including forums and conferences, technology exchanges,...



News published on and distributed by: